Finasteride Pellets

(Product under development)
Finasteride PelletsFinasteride (marketed by Merck under the trademark names Proscar and Propecia, also available under several generic names) is a synthetic antiandrogen that inhibits type II 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT).

In 1992, under the brand name Proscar, the U.S. Food and Drug Administration (FDA) initially approved finasteride to treatment benign prostatic hyperplasia (BPH). In 1997, the FDA approved finasteride to treat male pattern baldness (MPB) under the brand name Propecia.

Available Form:
Finasteride Pellets
Finasteride Granules

Umang Pharmatech equipments used for production of Finasteride Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Finasteride Pellets
Systematic (IUPAC) Name
Finasteride Pellets
Finasteride Pellets
Chemical data
(RS)- 2-[4-[1-Hydroxy- 4-[4-(hydroxy- diphenyl- methyl) - 1-piperidyl]butyl]phenyl]- 2-methyl- propanoic acid
CAS number : 83799-24-0
ATC code : R06AX26
PubChem : CID 3348
DrugBank : APRD00349
ChemSpider : 3231
KEGG : D07958
Formula : C32H39NO4
Mol. mass : 501.656

* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech